Received Feb 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
Severely shaking hands after second; Uncontrollable blood pressure; This non-serious case was reported by a consumer via patient support programs and described the occurrence of blood pressure inadequately controlled in a 59-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Concurrent medical conditions included blood pressure (controlled). Concomitant products included carvedilol. On 01-NOV-2022, the patient received the 2nd dose of Shingrix. On 03-NOV-2022, 2 days after receiving Shingrix, the patient experienced blood pressure inadequately controlled (Verbatim: Uncontrollable blood pressure). On 15-DEC-2022, the patient experienced tremor of hands (Verbatim: Severely shaking hands after second). The outcome of the blood pressure inadequately controlled was not resolved and the outcome of the tremor of hands was resolving. It was unknown if the reporter considered the blood pressure inadequately controlled and tremor of hands to be related to Shingrix. It was unknown if the company considered the blood pressure inadequately controlled and tremor of hands to be related to Shingrix. Additional Information: GSK Receipt Date: 08-JAN-2025 The patient had controlled blood pressure for more than 25 years with one medication. The patient's doctors have since changed the medication 7 times and finally put the patient on a Beta Blocker with bad side effects. The patient had been to the ER twice for extremely high Blood Pressure in the last two years. The patient never had an issue until receiving the two shots of Shingrix. The patient have more to share in future conversations. The patient had severely shaking hands after second dose. The symptoms were not treated. Consented to follow up.
Blood pressure (controlled)
CARVEDILOL